Last reviewed · How we verify
Amidofen (aminophenazone)
At a glance
| Generic name | aminophenazone |
|---|---|
| Drug class | aminophenazone |
| Target | Nicotinate phosphoribosyltransferase, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2 |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparing the Safety and Effectiveness of Different Doses of Morphine Administered in Spinal Anethesia for Pain Relief After Hip Replacement Surgery (PHASE4)
- Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs (NA)
- Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis. (NA)
- Comparison of the Effectiveness of Paracetamol With Ibuprofen or Paracetamol With Metamizole in Treating Pain in Acute Pancreatitis in Children (PHASE4)
- Antipyretic Treatment for Intrapartum Fever: Dipyrone vs Acetaminophen (RCT) (PHASE4)
- Fixed Dose Combination of COdeine + DIpyrone to Mitigate Moderate to Intense Pain Post-impacted Third Lower Molar Extraction (PHASE3)
- Fixed Combination of Dipirone and Codeine Compared to the Isolated Use of Dipyrone and Codeine in Controlling Pain After Pelvic-abdominal Surgery. (PHASE3)
- Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amidofen CI brief — competitive landscape report
- Amidofen updates RSS · CI watch RSS
- portfolio CI